Table 4.
Diagnostic efficacy of ROC curve between CHF-CPE group and CHF-control group.
| Parameter | Cut-off value | Sensitivity | Specificity | Yoden index | AUC | 95% CI | P-value |
|---|---|---|---|---|---|---|---|
| ΔSV (mL) | 5.039 | 87.93 | 76.67 | 0.646 | 0.830 | 0.729–0.931 | <0.001 |
| TAPSE/MAPSE | 1.917 | 53.45 | 80.00 | 0.334 | 0.656 | 0.541–0.771 | 0.017 |
| E/e’ | 13.043 | 96.55 | 80.00 | 0.766 | 0.918 | 0.842–0.994 | <0.001 |
| LAA-V (%) | 24.565 | 93.33 | 72.41 | 0.657 | 0.900 | 0.835–0.964 | <0.001 |
SV, The difference value between right ventricular stroke volume and left ventricular stroke volume; TAPSE/MAPSE, the ratio of tricuspid annular plane systolic excursion to mitral annular plane systolic excursion; E/e′, the ratio of early diastolic peak flow velocities of the mitral valve to peak diastolic velocities of the mitral annulus at septal and lateral; LAA-V, variation of left atrial area; LUS, lung ultrasound.